Lahey Hospital & Medical Center

Department of Pharmacy


Patrick K. Lam 
Lahey Hospital & Medical Center 
(781) 744-3658 


Thursday March 7, 2013 at 7:00 AM - 4:30 PM EDT

Friday March 8, 2013 at 7:00 AM - 2:00 PM EDT

Add to Calendar 


Waltham Woods Conference Center 
860 Winter Street
Waltham, MA 02451

Driving Directions 

Vendor Exhibit Information:

Vendor display will be in a designated area apart from the auditorium.

The vendor list is dynamic and reflects the most current vendor regiatration for the symposium.







Janssen Biotech


Merck Iufectious Diseases

Otsuka Pharmaceuticals

The Medicines Company












Spring 2013 Symposium 

featuring Medication Safety, Technology and Clinical Hot Topics

A Knowledge-Based CE Activity 

Spend 2 days with experts learning about cutting edge technology, Med Safety and other Hot Topics while earning 10.0 hours of ACPE credits.

Who Should Attend:

Pharmacists, nurses and other healthcare professionals from a variety of practice settings who are interested in advancing their knowledge in clinical practice and informatics.  Attendees will have a chance to attend a showcase of technology and drug information exhibits.

Accreditation Statement:

ACPE logo

Lahey Clinic is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.


Participants in this program will receive up to 10.0 contact hours (1.0 CEU) of ACPE credits including 2.0 hours of pharmacy law.


0389-0000-13-001-L05-P (1.0 CE hour or 0.1 CEU)
0389-0000-13-002-L01-P (1.0 CE hour or 0.1 CEU)
0389-0000-13-003-L05-P (1.0 CE hour or 0.1 CEU)
0389-0000-13-004-L05-P (1.0 CE hour or 0.1 CEU)
0389-0000-13-005-L01-P (1.0 CE hour or 0.1 CEU)
0389-0000-13-006-L03-P (1.0 CE hour or 0.1 CEU)
0389-0000-13-007-L04-P (1.0 CE hour or 0.1 CEU)
0389-0000-13-008-L05-P (1.0 CE hour or 0.1 CEU)
0389-0000-13-009-L05-P (1.0 CE hour or 0.1 CEU)

0389-0000-13-010-L03-P (1.0 CE hour or 0.1 CEU)

Requirements and Procedures:

Participants must attend all sessions to receive full CEU credits.  Participants will participate in program assessment using the audience response system throughout the program. All attendees must complete the signature sheets at the conclusion of the presentation and finish the online evaluations in order to receive credits for the program. Statements of credit will be uploaded onto the NABP website. Please allow 2-4 weeks for completion.

Registration Fee:

$145.00 USD for FULL registration

$90.00 for 1st Day

$60.00 for 2nd Day

Special registration discounts for:

Lahey Health Pharmacy Staff and NEPC Members (verification is required)


William W. Churchill, MS, RPh

Chief of Service
Pharmacy Department
Brigham and Women's Hospital

Boston, MA 

John Devlin, PharmD, FCCM, FCCP

Associate Professor, Department of Pharmacy Practice,
Northeastern University
Special and Scientific Staff, Division of Pulmonary
Critical Care and Sleep Medicine,
Tufts Medical Center
Adjunct Associate Professor, Tufts University School of Medicine

Boston, MA

Rick Doblin, PhD

Founder and Executive Director

Multidisciplinary Association for Psychedelic Studies (MAPS)

Karen Fiumara, PharmD, BCPS

Director of Patient Safety
Brigham and Women's Hospital

Boston, MA

Mary Beth Hodge, MD

Clinical Endocrinologist
Department of Endocrinology
Director of Endocrinology Fellowship Program
Lahey Hospital & Medical Center
Burlington, MA
Assistant Clinical Professor of Medicine

Tufts University School of Medicine

Jason W. Lancaster, PharmD, MEd, BCPS

Assistant Clinical Professor
Bouvé College of Health Sciences: School of Pharmacy-Department of Pharmacy Practice
Northeastern University
Internal Medicine Pharmacist
Lahey Hospital & Medical Center
Instructor of Medicine

Tufts University School of Medicine

Patrick Lewis, PharmD

Inpatient Anticoagulation Clinical Pharmacy Specialist
Lahey Hospital & Medical Center

Burlington, MA

Rachel Mikhil, PharmD

Medication Safety Specialist
UMass Memorial Medical Center - University Campus
Department of Pharmacy

Worcester, MA

Karen Ryle, RPh

Associate Chief of Pharmacy
Ambulatory Care
Massachusetts General Hospital

Boston, MA

Margie Sipe DNP, RN, NEA-BC

Nursing Performance Improvement Innovator
Lahey Hospital & Medical Center
Massachusetts General Hospital

Burlington, MA

Schedule of Events

7:00AM - 8:30AM

Vendor Exhibit / Continental Breakfast/ Registration

8:15AM - 8:30AM 

Welcome and Introduction

8:30AM - 9:30AM

IV Robotics in instituitional settings and their integration to improve safety and workflow 

William Churchill

After attending this session, the attendees should be able to:
  • Discuss the need for patient safety-related improvements our current IV admixture programs in health systems. 
  • Describe the pros and cons of the volumetric and gravimetric processes used in preparing Compounded Sterile Preparations (CSP). 
  • Describe at least two types of quality control testing that should be done when implementing a robotic or a gravimetrically-based system for CSP admixture preparation.
  • Describe at least two examples of improvements to patient care resulting from the integration of optical scanning and bar code verification into the compounded sterile preparation (CSP) process.
  • Identify at least two steps involved in developing a strategic plan for improving a health system’s’ process for preparing compounded sterile products

9:30AM - 10:30AM

Disease Management: Incretin Mimetics Therapy for Diabetes

Mary Beth Hodge

After this session, the attendees should be able to:

  • Recognize the factors contributing to poor glycemic control in Type II Diabetes
  • Explain the impaired Incretin effect in Type II Diabetes
  • Describe the role of Incretins in maintaining glucose homeostasis
  • Determine the clinical utility of Incretin Mimetics in the management of Type II Diabetes
  • 10:30AM - 10:45AM

    ~ Refreshment BREAK ~

    10:45AM -11:45AM

    Workarounds and loop holes with technology: Is BCMA the best solution to prevent medication errors?

    Margie Sipe

    After this session, the attendees should be able to:

    • Describe 2 reasons barcode medication administration may not catch all errors.
    • Discuss some common reasons nurses resort to “workarounds” when delivering medications using BCMA
    • Define partnering opportunities with pharmacists, nurses, patients, and technology that can enhance medication error prevention
    • Assess factors in the environment that can be the source of latent errors
    • Identify 2 ways focus on errors can be executed during the medication administration process

    11:45 AM to 1:15 PM


    1:15AM to 2:15 PM

    Medication safety in the context of "hospital safety" and how to keep "med safety" on the radar screen for hospital leadership

    Karen Fiumara

    After this session, the attendee should be able to:

    • Identify key drivers of patient safety priorities
    • Evaluate the importance of keeping medication safety a top priority
    • Identify strategies to ensure medication safety is a top priority for hospital safety

    2:15 PM to 3:15 PM

    Smart pump technology and its integration in medication safety

    Rachel Mikhil

    After attending this session, the attendees should be able to:

    • Explain the benefits and safety features of SMART pump technology
    • Discuss the role of SMART pump technology in preventing medication errors
    • Determine the process needed to prepare for implementation of SMART pump technology

    3:15 PM to 3:30 PM

    ~ Refreshment BREAK ~

    3:30 PM to 4:30 PM

    Regulation of medical uses of Schedule 1 drugs, the political obstacles blocking the FDA-approved medical maijuana research, and marijuana for PTSD

    Rick Doblin

    After this session, the attendees should be able to:

    • Describe the regulation of medical uses of Schedule 1 drugs
    • Discuss the political obstacles blocking FDA-approved medical marijuana research
    • Explain the proposed protocol to investigate the safety and efficacy of five different potencies of smoked or vaporized marijuana in fifty veterans with chronic, treatment-resistant post traumatic stress disorder

    4:30 PM


    ~ Day 2 (March 8)~

    Schedule of Events

    7:00AM - 8:30AM

    Vendor Exhibit / Continental Breakfast/ Registration

    8:15AM - 8:30AM 

    Welcome and Introduction

    8:30AM - 9:30AM

    Precepting and Mentorship: How to maximize talent

    Jason Lancaster

    After attending this session, the attendees should be able to:
    • Identify qualities of a good mentor/preceptor, including accreditation requirements 
    • Outline attributes that foster positive preceptor/mentor relationships
    • Create a plan to establish, or enhance, preceptorship/mentorship at your workplace

    9:30AM - 10:30AM

    Recognition, prevention and treatment of delirium in hospitalized patients: The expanding role of for pharmacists

    John Devlin

    After attending this session, the attendees should be able to:

    • Understand the risk factors and sequela of delirium in hospitalized patients.
    • Recognize delirium using a validated screening tool
    • Formulate a plan to prevent delirium in acutely ill patients
    • Devise an algorithm for the treatment of delirium in your patients

    10:30AM - 11:00AM

    ~ Refreshment BREAK/ EXHIBIT ~

    11:00AM -12:00PM

    Traversing the landscape of oral anticoagulation in atrial fibrillation: a focus on safety and efficacy of emerging anticoagulants

    Patrick Lewis

    After this session, the attendees should be able to:

    • Evaluate recent data on thromboprophylactic treatments for atrial fibrillation including the benefits and risks of emerging anticoagulants
    • Explain patient-centered strategies to improve safety and efficacy of emerging anticoagulants in the treatment of atrial fibrillation
    • Discuss drug-specific factors that may affect dosing, monitoring, and reversal of emerging anticoagulants

    12:00PM to 1:00PM


    1:00PM to 2:00PM

    Pharmacy Law Update: Overview of the Massachusetts Prescription Monitoring Program

    Karen Ryle

    After this session, the attendee should be able to:

    • Discuss the Implementation of Chapter 244 of the Acts of 2012-An Act Relative to Prescription Drug Diversion, Abuse and Addiction
    • Describe both the Prescriber and Pharmacist’s role in the use of the prescription monitoring program (PMP)
    • Understand the pharmacist’s corresponding responsibility when filling prescriptions for controlled substances